Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Tempe… (NCT07507396) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Temperature Management: Evaluation of Temple Touch Pro
United States20 participantsStarted 2026-05
Plain-language summary
The purpose of this study is to evaluate the Temple Touch Pro (TTP) in Pediatric Intensive Care Unity (PICU) patients requiring targeted temperature control.
Who can participate
Age range0 Years – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 0 to less than 18 years of age
✓. PICU Diagnosis requiring targeted temperature management. For example traumatic brain injury, cardiac arrest, or anoxic brain injury
✓. Requires continuous temperature monitoring with a foley catheter (bladder) or a general purpose probe placed in the esophagus.
✓. Enrolled within 24 hours of start of continuous temperature monitoring.
✓. Patient has adequate forehead space to accommodate the TTP sensor
✓. Temporal artery perfusion not compromised by injury or other pathology
✓. No surgical procedure planned for 72 hours
✓. Targeted temperature management expected for at least 24 hours at time of consent
Exclusion criteria
✕. Already enrolled in another trial addressing temperature management
✕. Allergy to medical grade acrylic adhesive
✕. Patient does not tolerate placement of TTP sensor on forehead
✕. Contraindication to the placement of two or more of Foley, esophageal, and rectal temperature probes.
✕. A history of skin irritation, skin sensitivity, or skin disease, including psoriasis, eczema, atopic dermatitis, and skin cancer.
What they're measuring
1
Analysis of temperature pairs between TTP and three core locations
Timeframe: From enrollment to the end of treatment (min. 10 hours)